AR080430A1 - Una composicion farmaceutica de matriz - Google Patents

Una composicion farmaceutica de matriz

Info

Publication number
AR080430A1
AR080430A1 ARP110100242A ARP110100242A AR080430A1 AR 080430 A1 AR080430 A1 AR 080430A1 AR P110100242 A ARP110100242 A AR P110100242A AR P110100242 A ARP110100242 A AR P110100242A AR 080430 A1 AR080430 A1 AR 080430A1
Authority
AR
Argentina
Prior art keywords
galantamine
matrix composition
micrometers
polymer particles
average particle
Prior art date
Application number
ARP110100242A
Other languages
English (en)
Spanish (es)
Inventor
Sing-Hoon Kam
Jae-Soon Ahn
Jae-Keol Rhee
Original Assignee
Hyundai Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyundai Pharm Co Ltd filed Critical Hyundai Pharm Co Ltd
Publication of AR080430A1 publication Critical patent/AR080430A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP110100242A 2010-01-26 2011-01-25 Una composicion farmaceutica de matriz AR080430A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2010/000469 WO2011093535A1 (ko) 2010-01-26 2010-01-26 갈란타민을 포함한 매트릭스 형태의 약학 조성물

Publications (1)

Publication Number Publication Date
AR080430A1 true AR080430A1 (es) 2012-04-11

Family

ID=44319504

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100242A AR080430A1 (es) 2010-01-26 2011-01-25 Una composicion farmaceutica de matriz

Country Status (4)

Country Link
AR (1) AR080430A1 (pt)
BR (1) BRPI1005440A2 (pt)
MX (1) MX2011005725A (pt)
WO (1) WO2011093535A1 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2551946A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galantamine
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
WO2007029081A1 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Galantamine-containing controlled release oral dosage forms, processes for the preparation thereof and use for the manufacture of a medicament
US7955622B2 (en) * 2006-10-13 2011-06-07 Actavis Group Ptc Hf Controlled-release galantamine formulations
KR100782310B1 (ko) * 2007-03-22 2007-12-06 현대약품 주식회사 갈란타민 또는 이의 약학적으로 허용 가능한 염을 포함하는약학 조성물
EP2044933A1 (en) * 2007-10-05 2009-04-08 KRKA, D.D., Novo Mesto Multi particulate matrix system containing galantamine

Also Published As

Publication number Publication date
WO2011093535A1 (ko) 2011-08-04
BRPI1005440A2 (pt) 2016-03-08
MX2011005725A (es) 2011-08-30

Similar Documents

Publication Publication Date Title
EA201400172A1 (ru) Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
HRP20200600T1 (hr) Tapentadol za sprječavanje i liječenje depresije i tjeskobe
CO2017007003A2 (es) Formulaciones de sunitinib y métodos para uso de las mismas en el tratamiento de trastornos oculares
JP2010222367A5 (pt)
PE20200175A1 (es) Formas de dosificacion de ruxolitinib de liberacion sostenida
CL2013003331A1 (es) Tableta de liberacion inmediata a prueba de alteracion que comprende (i) una matriz, y (ii) una pluralidad de material particulado, que comprende un opiaceo y un polimero de oxido de polietileno de mas de 20.000 g/mol, donde el multiparticulado forma una fase discontinua dentro de la matriz.
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
EA201491710A1 (ru) Препараты с контролируемым высвобождением для доставки ингибиторов hif-1
CO6670598A2 (es) Forma de dosificación resistente a alteración que comprende un polímero aniónico
JP2012530141A5 (pt)
PE20141115A1 (es) Comprimido de desintegracion oral
JP2015523407A5 (pt)
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
UA108885C2 (uk) Композиція рисперидону для ін'єкційної депо-форми
EA201491479A1 (ru) Производные лупановых тритерпеноидов и их фармацевтическое применение
MY168609A (en) 4-alkynyl imidazole derivative and medicine comprising same as active ingredient
AR077284A1 (es) Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica
NZ595046A (en) Compositions and methods for extended therapy with aminopyridines
ECSP14013200A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
CO6382109A2 (es) Formulación de depósito de octreotida con niveles de exposición constantemente altos
EA201391689A1 (ru) Система доставки лекарственного средства
CO6640318A2 (es) Formas de dosificación oral de bendamustina
AR062239A1 (es) Composicion farmaceutica sinergica util para inhibir la neovascularizacion (angiogenesis) corneal y retinal, y de otros organos, en un humano o animal
AR080256A1 (es) Formulaciones farmaceuticas solidas de ramipril y besilato de amlodipino y su preparacion
AR080430A1 (es) Una composicion farmaceutica de matriz

Legal Events

Date Code Title Description
FB Suspension of granting procedure